podocyte viability Search Results


podocyte viability  (Dojindo Labs)
99
Dojindo Labs podocyte viability
Protective impact of MSCs‐Exo on podocytes. (A, <t>B)</t> <t>Viability</t> of podocytes exposed to varying concentrations of AGEs and HG for 48 h ( n = 3). (C, D) <t>Podocyte</t> viability following treatment with escalating concentrations of EGCG under HG (30 mM) and AGEs (200 μg/mL) for 48 h ( n = 3). (E, G) Flow cytometric analysis summarizing podocyte apoptosis in response to 30 mM HG, with or without 30 μM EGCG, over 48 h ( n = 3). (F, H) Flow cytometric analysis summarizing podocyte apoptosis in response to 200 μg/mL AGEs, with or without 40 μM EGCG, over 48 h ( n = 3). (I) HMGB1 expression levels in podocytes exposed to 30 mM HG with or without 30 μM EGCG for 48 h. Values are shown as means±SD. *** p < 0.001, ** p < 0.01, * p < 0.05.
Podocyte Viability, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocyte+viability/pmc11666909-56-0-9?v=Dojindo+Labs
Average 99 stars, based on 1 article reviews
podocyte viability - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
podocyte viability  (Beyotime)
99
Beyotime podocyte viability
Protective impact of MSCs‐Exo on podocytes. (A, <t>B)</t> <t>Viability</t> of podocytes exposed to varying concentrations of AGEs and HG for 48 h ( n = 3). (C, D) <t>Podocyte</t> viability following treatment with escalating concentrations of EGCG under HG (30 mM) and AGEs (200 μg/mL) for 48 h ( n = 3). (E, G) Flow cytometric analysis summarizing podocyte apoptosis in response to 30 mM HG, with or without 30 μM EGCG, over 48 h ( n = 3). (F, H) Flow cytometric analysis summarizing podocyte apoptosis in response to 200 μg/mL AGEs, with or without 40 μM EGCG, over 48 h ( n = 3). (I) HMGB1 expression levels in podocytes exposed to 30 mM HG with or without 30 μM EGCG for 48 h. Values are shown as means±SD. *** p < 0.001, ** p < 0.01, * p < 0.05.
Podocyte Viability, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/podocyte+viability/pm40258521-89-12-22?v=Beyotime
Average 99 stars, based on 1 article reviews
podocyte viability - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

Image Search Results


Protective impact of MSCs‐Exo on podocytes. (A, B) Viability of podocytes exposed to varying concentrations of AGEs and HG for 48 h ( n = 3). (C, D) Podocyte viability following treatment with escalating concentrations of EGCG under HG (30 mM) and AGEs (200 μg/mL) for 48 h ( n = 3). (E, G) Flow cytometric analysis summarizing podocyte apoptosis in response to 30 mM HG, with or without 30 μM EGCG, over 48 h ( n = 3). (F, H) Flow cytometric analysis summarizing podocyte apoptosis in response to 200 μg/mL AGEs, with or without 40 μM EGCG, over 48 h ( n = 3). (I) HMGB1 expression levels in podocytes exposed to 30 mM HG with or without 30 μM EGCG for 48 h. Values are shown as means±SD. *** p < 0.001, ** p < 0.01, * p < 0.05.

Journal: Food Science & Nutrition

Article Title: Epigallocatechin‐3‐Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP / NLRP3 / IL ‐1β Signaling Pathway

doi: 10.1002/fsn3.4617

Figure Lengend Snippet: Protective impact of MSCs‐Exo on podocytes. (A, B) Viability of podocytes exposed to varying concentrations of AGEs and HG for 48 h ( n = 3). (C, D) Podocyte viability following treatment with escalating concentrations of EGCG under HG (30 mM) and AGEs (200 μg/mL) for 48 h ( n = 3). (E, G) Flow cytometric analysis summarizing podocyte apoptosis in response to 30 mM HG, with or without 30 μM EGCG, over 48 h ( n = 3). (F, H) Flow cytometric analysis summarizing podocyte apoptosis in response to 200 μg/mL AGEs, with or without 40 μM EGCG, over 48 h ( n = 3). (I) HMGB1 expression levels in podocytes exposed to 30 mM HG with or without 30 μM EGCG for 48 h. Values are shown as means±SD. *** p < 0.001, ** p < 0.01, * p < 0.05.

Article Snippet: Podocyte viability was examined using a cell counting kit‐8 (Dojindo, Japan).

Techniques: Expressing